CRTonline Podcast
CRTonline Podcast features interviews with well-known physicians about medical journals and ongoing issues in medicine. It explores current research, clinical topics, and developments in healthcare. The show is aimed at medical professionals and anyone interested in the world of medicine.
Episodes
The POPular ACE TAVI trial: routine or selective protamine administration after TAVI?
The POPular ACE TAVI trial: routine or selective protamine administration after TAVI?
AIR-STEMI trial: Functional Coronary Angiography in STEMI
AIR-STEMI trial: Functional Coronary Angiography in STEMI
A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI
A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI
SWITCH SWEDEHEART - Switching from ticagrelor to prasugrel in patients with ACS
SWITCH SWEDEHEART - Switching from ticagrelor to prasugrel in patients with ACS
AMUNDSEN: Evolocumab Before PCI for AMI
AMUNDSEN: Evolocumab Before PCI for AMI
King and I | S7 E3 | DNR/DNI Patients and Heart Surgery: When Is Intervention Ethical?
King and I | S7 E3 | DNR/DNI Patients and Heart Surgery: When Is Intervention Ethical?
Anticoagulation for atrial fibrillation with intermediate stroke risk: The SINGLE-AF trial
Anticoagulation for atrial fibrillation with intermediate stroke risk: The SINGLE-AF trial
Experts Talk: About the VICTORY trial and HOW to Improve the Outcome in Complex PCI
Experts Talk: About the VICTORY trial and HOW to Improve the Outcome in Complex PCI
King and I | S7 E4 | AI and Medical Education
King and I | S7 E4 | AI and Medical Education
King and I | S7 E3 | DNR/DNI Patients and Heart Surgery: When Is Intervention Ethical?
King and I | S7 E3 | DNR/DNI Patients and Heart Surgery: When Is Intervention Ethical?
Long-term mortality following PCI with DES vs. CABG for left main disease
Long-term mortality following PCI with DES vs. CABG for left main disease
King and I | S7 E1 | Politics of Federal Funding Cuts
King and I | S7 E1 | Politics of Federal Funding Cuts
Coronary revascularization in patients undergoing TAVI: an IPD meta-analysis of four randomized trials
Coronary revascularization in patients undergoing TAVI: an IPD meta-analysis of four randomized trials
King and I | S6 E10 | Should we keep the NCD for TAVR?
King and I | S6 E10 | Should we keep the NCD for TAVR?
Sirolimus eluting balloon in complex PCI: evidence from the SELUTION De Novo trial
Sirolimus eluting balloon in complex PCI: evidence from the SELUTION De Novo trial
Three-Year Outcomes of the SMART Trial
Three-Year Outcomes of the SMART Trial
King and I | S6 E9 | Should Recent Clinical Evidence Change How We Use Intravascular Imaging–Guided PCI
King and I | S6 E9 | Should Recent Clinical Evidence Change How We Use Intravascular Imaging–Guided PCI
Capstan Compass Robotic System TM
Capstan Compass Robotic System TM
Illuminating The Nervous System with Transvascular Precision-guided Technology
Illuminating The Nervous System with Transvascular Precision-guided Technology
Assist@cor / The Phoenix Heart: We Assist Your Heart Until Full Recovery
Assist@cor / The Phoenix Heart: We Assist Your Heart Until Full Recovery
The TFX Platform: Reimagining Access for Complex Endovascular Procedures
The TFX Platform: Reimagining Access for Complex Endovascular Procedures
Adaptive Coaptation for Treating TR - First Use of DUO Adapt
Adaptive Coaptation for Treating TR - First Use of DUO Adapt
Evaluating Standard Shielding Versus Novel Enhanced Radiation Protection Devices (ERDPS) In the Cardiac Catheterization Laboratory
Evaluating Standard Shielding Versus Novel Enhanced Radiation Protection Devices (ERDPS) In the Cardiac Catheterization Laboratory
Lifetime Cost-effectiveness Analysis of Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis for Intermediate-risk Pulmonary Embolism in the United States
Lifetime Cost-effectiveness Analysis of Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis for Intermediate-risk Pulmonary Embolism in the United States
Oct-shield Vulnerable Plaque Identification And Stabilization Catheter System and SmartFlow Percutaneous Venous Valve
Oct-shield Vulnerable Plaque Identification And Stabilization Catheter System and SmartFlow Percutaneous Venous Valve
DCB for De-Novo Lesions
DCB for De-Novo Lesions
LearUp: Driving MedTech Innovation Through Digital Technologies
LearUp: Driving MedTech Innovation Through Digital Technologies
Smart Aortic Valve With Pacemaking Capabilities
Smart Aortic Valve With Pacemaking Capabilities
Disparities in Research
Disparities in Research
Angio + CT‑FFR: A Smarter CAD Pathway
Angio + CT‑FFR: A Smarter CAD Pathway
Management of Shock in 2026
Management of Shock in 2026
2026 Updates in CMD
2026 Updates in CMD
LBCT: Four-year Hemodynamic Outcomes with An Intra-annular, Self- Expandable Transcatheter Aortic Valve
LBCT: Four-year Hemodynamic Outcomes with An Intra-annular, Self- Expandable Transcatheter Aortic Valve
LBCT: Outcomes Of Patients Who Were Ineligible for Transcatheter Mitral Valve Replacement Trials: Insight from a Multicenter Registry
LBCT: Outcomes Of Patients Who Were Ineligible for Transcatheter Mitral Valve Replacement Trials: Insight from a Multicenter Registry
LBCT: Health Status Outcomes Seven Years After Transcatheter or Surgical Aortic Valve Replacement in Low Surgical Risk Patients with Severe Aortic Stenosis
LBCT: Health Status Outcomes Seven Years After Transcatheter or Surgical Aortic Valve Replacement in Low Surgical Risk Patients with Severe Aortic Stenosis
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
LBCT: Six-year Outcomes of Patients with Aortic Stenosis in The Evolut Low Risk Trial
LBCT: Six-year Outcomes of Patients with Aortic Stenosis in The Evolut Low Risk Trial
LBCT: Interleukin-6 Inhibition in Acute Myocardial Infarction at Risk of Cardiogenic Shock: A Randomized Controlled Trial
LBCT: Interleukin-6 Inhibition in Acute Myocardial Infarction at Risk of Cardiogenic Shock: A Randomized Controlled Trial
LBCT: SELUTION DeNovo: New Insights from the 12 Month Outcomes
LBCT: SELUTION DeNovo: New Insights from the 12 Month Outcomes
LBCT: Efficacy And Safety of Clopidogrel Versus Aspirin Monotherapy Beyond 12 Months After PCI In Patients at High Risk of Subsequent Cardiovascular Event
LBCT: Efficacy And Safety of Clopidogrel Versus Aspirin Monotherapy Beyond 12 Months After PCI In Patients at High Risk of Subsequent Cardiovascular Event
LBCT: The Laplace Transcatheter Tricuspid Valve Replacement System: EFS Update
LBCT: The Laplace Transcatheter Tricuspid Valve Replacement System: EFS Update
LBCT: Health Status Outcomes Seven Years After Transcatheter or Surgical Aortic Valve Replacement in Low Surgical Risk Patients with Severe Aortic Stenosis
LBCT: Health Status Outcomes Seven Years After Transcatheter or Surgical Aortic Valve Replacement in Low Surgical Risk Patients with Severe Aortic Stenosis
LBCT: Trisol Early Feasibility Study Outcomes Including Patients with Reduced RV Function
LBCT: Trisol Early Feasibility Study Outcomes Including Patients with Reduced RV Function
LBCT: Repeat Intervention After Failed Transcatheter Aortic Valve Implantation (TAVI): Outcomes of Redo TAVI Versus Surgical Explantation
LBCT: Repeat Intervention After Failed Transcatheter Aortic Valve Implantation (TAVI): Outcomes of Redo TAVI Versus Surgical Explantation
LBCT: Transfemoral J-Valve System for Chronic Aortic Regurgitation: Initial Post-market In-Hospital Experience In 236 Patients
LBCT: Transfemoral J-Valve System for Chronic Aortic Regurgitation: Initial Post-market In-Hospital Experience In 236 Patients
LBCT: TAVI CLOSE: Dual Suture Vs Single Suture and Plug Closure in Transfemoral TAVI
LBCT: TAVI CLOSE: Dual Suture Vs Single Suture and Plug Closure in Transfemoral TAVI
LBCT: Long-term Outcomes of Women and Men Undergoing Self-Expanding Vs. Balloon Expandable Valves: A Sex-specific Analysis Of The SOLVE-TAVI Trial
LBCT: Long-term Outcomes of Women and Men Undergoing Self-Expanding Vs. Balloon Expandable Valves: A Sex-specific Analysis Of The SOLVE-TAVI Trial
Paclitaxel-coated Versus Uncoated Balloon For Coronary In-stent Restenosis - Three-year Outcomes Of The Agent Ide Trial
Paclitaxel-coated Versus Uncoated Balloon For Coronary In-stent Restenosis - Three-year Outcomes Of The Agent Ide Trial
INNOVATION COMPETITION: Retrievable Scaffold Therapy: The Spur Elute Coronary Retrievable Scaffold System
INNOVATION COMPETITION: Retrievable Scaffold Therapy: The Spur Elute Coronary Retrievable Scaffold System
LBCT: Effect Of Low-dose Dobutamine Infusion On N-terminal Pro B-type Natriuretic Peptide In Risk Patients With Acute Myocardial Infarction (DOBERMANN-D) - A Randomized Clinical Trial
LBCT: Effect Of Low-dose Dobutamine Infusion On N-terminal Pro B-type Natriuretic Peptide In Risk Patients With Acute Myocardial Infarction (DOBERMANN-D) - A Randomized Clinical Trial
LBCT: Novel Balloon-expandable Transcatheter Heart Valve For Aortic Stenosis: Initial Insights From The Early Feasibility Study
LBCT: Novel Balloon-expandable Transcatheter Heart Valve For Aortic Stenosis: Initial Insights From The Early Feasibility Study
Wellness of Female Interventional Cardiologists in the Cath Lab
Wellness of Female Interventional Cardiologists in the Cath Lab
Wellness of Interventional Cardiologists in the Cath Lab
Wellness of Interventional Cardiologists in the Cath Lab
CRT and SCAI Partnership
CRT and SCAI Partnership
Comparison of a Hands-Free, Fully Automated Segmentation Angiography-Derived Fractional Flow Reserve, X1-FFR, With Invasive Wire-based Hyperemic FFR
Comparison of a Hands-Free, Fully Automated Segmentation Angiography-Derived Fractional Flow Reserve, X1-FFR, With Invasive Wire-based Hyperemic FFR
King and I | S6 E8 | Long-Term Follow-Up after TAVR and What Signal Should be Urgently Reported to the Public
King and I | S6 E8 | Long-Term Follow-Up after TAVR and What Signal Should be Urgently Reported to the Public
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
AI in Cardiology
AI in Cardiology
AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry
AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry
The PROMISE Trial
The PROMISE Trial
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
PROCTOR: A Multicenter, Open-label, Randomized Trial
PROCTOR: A Multicenter, Open-label, Randomized Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
The OCVC-BIF Study
The OCVC-BIF Study
The INFINITY-SWEDEHEART Randomized Trial
The INFINITY-SWEDEHEART Randomized Trial
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Results from STORM-PE - Randomized Controlled Trial
Results from STORM-PE - Randomized Controlled Trial
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
The Short-CUT Trial
The Short-CUT Trial
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
One-Year Results of the SELUTION DeNovo Tria
One-Year Results of the SELUTION DeNovo Tria
King and I | S6 E5 | PCI: Back to the Balloon
King and I | S6 E5 | PCI: Back to the Balloon
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
PULSE Randomized Controlled Trial
PULSE Randomized Controlled Trial
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
Age Analysis of the MCS in CS Meta Analysis
Age Analysis of the MCS in CS Meta Analysis
